Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4283-4286, October 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Betz, C.
Right arrow Articles by Müller-Hermelink, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Betz, C.
Right arrow Articles by Müller-Hermelink, H. K.

Surfactant Protein Gene Expression in Metastatic and Micrometastatic Pulmonary Adenocarcinomas and Other Non-Small Cell Lung Carcinomas: Detection by Reverse Transcriptase-Polymerase Chain Reaction1

Christoph Betz, Thomas Papadopoulos2, Jürgen Buchwald, Jobst Dämmrich and Hans Konrad Müller-Hermelink

Institute of Pathology and Department of Thoracic Surgery, Julius Maximilians University, Josef-Schneider Strasse 2, 97080 Würzburg, Federal Republic of Germany

Reverse transcriptase (RT)-PCR with primers specific for surfactant protein A (SP-A), B (SP-B), C (SP-C), and D (SP-D) genes was applied to detect metastatic non-small cell lung carcinomas. Forty-one paratracheal and subcarinal lymph nodes obtained from 41 patients with non-small cell lung carcinomas, 11 lymph nodes from 11 patients with extrapulmonary adenocarcinomas, and eight control lymph nodes from patients without cancer were analyzed using RT-PCR. PCR products corresponding to SP-B gene products were found in all eight control lymph nodes, offering evidence of SP-B gene expression in cells of lymphatic tissue. SP-A, SP-C, and/or SP-D transcripts were detected in 11 (84.6%) of 13 lymph nodes with histologically identifiable metastases of pulmonary adenocarcinomas and in 10 (55.5%) of 18 lymph nodes that were tumor free on routine histological examination. These findings provide evidence of micrometastatic nodal involvement which remains undetectable by conventional light microsopy but can be evaluated by surfactant RT-PCR. Gene expression of SP-A and SP-C was restricted to metastatic pulmonary adenocarcinomas but SP-D gene activity has been also detected in two of four metastases of pulmonary large cell carcinomas, one adenosquamous carcinoma, and nine extrapulmonary adenocarcinomas as well.

1 This work was supported by a grant from the Dr. Mildred Scheel Stiftung/Deutsche Krebshilfe (Bonn, Germany).

2 To whom requests for reprints should be addressed.

Received 6/14/95. Accepted 6/18/95.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. M. Serra, A. Gutierrez, R. Alemany, M. Navarro, T. Ros, C. Saus, J. Gines, A. Sampol, J. C. Amat, L. Serra-Moises, et al.
Inhibition of c-Myc Down-Regulation by Sustained Extracellular Signal-Regulated Kinase Activation Prevents the Antimetabolite Methotrexate- and Gemcitabine-Induced Differentiation in Non-Small-Cell Lung Cancer Cells
Mol. Pharmacol., June 1, 2008; 73(6): 1679 - 1687.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Xi, M. C. Coello, V. R. Litle, S. Raja, W. E. Gooding, S. A. Yousem, T. El-Hefnawy, R. J. Landreneau, J. D. Luketich, and T. E. Godfrey
A Combination of Molecular Markers Accurately Detects Lymph Node Metastasis in Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., April 15, 2006; 12(8): 2484 - 2491.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Jiang, N. P. Caraway, B. Nebiyou Bekele, H.-Z. Zhang, A. Khanna, H. Wang, R. Li, R. L. Fernandez, T. M. Zaidi, D. A. Johnston, et al.
Surfactant Protein A Gene Deletion and Prognostics for Patients with Stage I Non-Small Cell Lung Cancer
Clin. Cancer Res., August 1, 2005; 11(15): 5417 - 5424.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Zhang, W. Pao, S. M. Umphress, S. B. Jakowlew, A. M. Meyer, L. D. Dwyer-Nield, L. D. Nielsen, K. Takeda, E. W. Gelfand, J. H. Fisher, et al.
Serum Levels of Surfactant Protein D Are Increased in Mice with Lung Tumors
Cancer Res., September 15, 2003; 63(18): 5889 - 5894.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
X. Jiao and M. J. Krasna
Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology
Ann. Thorac. Surg., July 1, 2002; 74(1): 278 - 284.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. G. Brinker, E. Martin, P. Borron, E. Mostaghel, C. Doyle, C. V. Harding, and J. R. Wright
Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells
Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1453 - L1463.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. J. Mason, M. Kalina, L. D. Nielsen, A. M. Malkinson, and J. M. Shannon
Surfactant Protein C Expression in Urethane-Induced Murine Pulmonary Tumors
Am. J. Pathol., January 1, 2000; 156(1): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Maruyama, K. Sugio, T. Mitsudomi, G. Saitoh, T. Ishida, and K. Sugimachi
RELATIONSHIP BETWEEN EARLY RECURRENCE AND MICROMETASTASES IN THE LYMPH NODES OF PATIENTS WITH STAGE I NON-SMALL-CELL LUNG CANCER
J. Thorac. Cardiovasc. Surg., October 1, 1997; 114(4): 535 - 543.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Dobashi, K. Sugio, T. Osaki, T. Oka, and K. Yasumoto
MICROMETASTATIC P53-POSITIVE CELLS IN THE LYMPH NODES OF NON-SMALL-CELL LUNG CANCER: PROGNOSTIC SIGNIFICANCE
J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 339 - 346.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.